FogPharma IPO: Investment Opportunities & Pre-IPO Valuations

Learn more about FogPharma

To invest in FogPharma pre-IPO

Can you invest in FogPharma pre-IPO?

FogPharma is a privately held company and is not publicly traded, therefore investing in FogPharma pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can learn more about Forge’s Secondary Marketplace and how to invest in private companies before their potential IPO. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

Can you sell shares of FogPharma before it goes public?

You can seek to sell your shares in FogPharma while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

What is the pre-IPO value of my FogPharma shares?

To determine the value of your FogPharma shares, create a free account to gain access to Forge’s platform. In addition to the Forge Price, Forge Markets contains pricing information for hundreds of pre-IPO companies such as Last Closed Trade Price. A Private Market Specialist will also be available to assist you with any inquiries related to your FogPharma shares. You can also learn more about how to sell your private shares before getting started.

Is FogPharma a publicly traded company?

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

To learn more about FogPharma potential IPO

Will FogPharma go IPO?

FogPharma has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is FogPharma’s IPO price?

The FogPharma IPO price does not exist at this time, as FogPharma is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to FogPharma register for Forge Markets, today.

When was FogPharma founded?

FogPharma was founded in 2016.

What is FogPharma funding to date?

FogPharma has raised $868.26MM to date.

Who are FogPharma’s major investors?

Casdin Capital

General Catalyst

Ra Capital Management

Arch Venture Partners

Fidelity Management & Research

T. Rowe Price

Horizons Ventures

Foresite Capital

Farallon Capital Management

Rock Springs Capital

Deerfield Management

Cormorant Asset Management

The Invus Group

Samsara Biocapital

venBio

Catalio Capital Management

Sixty Degree Capital

SymBiosis Capital Management

HBM Healthcare Investments

WuXi AppTec

6 Dimensions Capital

Milky Way Investments Group

PagsGroup

Blue Pool Capital

Leerink Partners

Pivotal Life Sciences

Boyu Capital

FogPharma Funding Rounds and Valuation

Funding History Chart

Funding Round Details

	Funding Date	Share Class	Amount Raised	Price per Share	Post-Money Valuation	Key Investors
	03/01/2024	Series E	$145MM	$xx.xx	$491.9MM	Nextech Invest, RA Capital Management, Rock Springs Capital, General Catalyst, Marshall Wace, Samsara Biocapital, Foresite Capital, Symbiosis, Catalio Capital Management, Sixty Degree Capital, Alex Gorsky
Price per Share $xx.xx Shares Outstanding 23,281,563 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 800.0% Cumulative Cumulative Participating Participating Participation Cap 1000 Key Investors Nextech Invest, RA Capital Management, Rock Springs Capital, General Catalyst, Marshall Wace, Samsara Biocapital, Foresite Capital, Symbiosis, Catalio Capital Management, Sixty Degree Capital, Alex Gorsky
	11/21/2022	Series D	$178MM	$xx.xx	$406.53MM	ARCH Venture Partners, Milky Way Investments, Fidelity, VenBio Partners, Deerfield Management, GV, Cormorant Asset Management, T. Rowe Price, Invus, Farallon Capital Management, HBM Healthcare Investments, Casdin Capital, PagsGroup
Price per Share $xx.xx Shares Outstanding 16,537,979 Liquidation Pref Order 2 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.2x Dividend Rate 800.0% Cumulative Cumulative Participating Participating Participation Cap 1000 Key Investors ARCH Venture Partners, Milky Way Investments, Fidelity, VenBio Partners, Deerfield Management, GV, Cormorant Asset Management, T. Rowe Price, Invus, Farallon Capital Management, HBM Healthcare Investments, Casdin Capital, PagsGroup
	03/01/2021	Series C	$107MM	$xx.xx	$262.08MM	VenBio Partners, Cormorant Asset Management, Farallon Capital Management, Invus, GV, 6 Dimensions Capital, Deerfield Management, Blue Pool Capital
Price per Share $xx.xx Shares Outstanding 7,384,710 Liquidation Pref Order 3 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.4x Dividend Rate 800.0% Cumulative Cumulative Participating Participating Participation Cap 1000 Key Investors VenBio Partners, Cormorant Asset Management, Farallon Capital Management, Invus, GV, 6 Dimensions Capital, Deerfield Management, Blue Pool Capital
	05/16/2018	Series B	$65.51MM	$xx.xx	$131.82MM	6 Dimensions Capital, GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group, Lerrink Partners, Deerfield Management, Boyu Capital, WuXi AppTec Corporate Ventures
Price per Share $xx.xx Shares Outstanding 4,658,112 Liquidation Pref Order 4 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.3x Dividend Rate 800.0% Cumulative Cumulative Participating Participating Participation Cap 1000 Key Investors 6 Dimensions Capital, GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group, Lerrink Partners, Deerfield Management, Boyu Capital, WuXi AppTec Corporate Ventures
	05/25/2016	Series A	$11.11MM	$xx.xx	$37.05MM	Deerfield Management
Price per Share $xx.xx Shares Outstanding 1,434,062 Liquidation Pref Order 5 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.1x Dividend Rate 800.0% Cumulative Cumulative Participating Participating Participation Cap 1000 Key Investors Deerfield Management

Access Stock Price

Frequently Asked Questions

Updated on: Nov 21, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.

FogPharma IPO

Register for Details